| Authors: |
Wang CC; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: chao-chi.wang@kuleuven.be., Barkholt P; Adcendo ApS, Copenhagen, Denmark. Electronic address: pernille.barkholt@adcendo.com., Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Lee CJ; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., De Sutter L; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., De Cock L; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium., Verbeeck K; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Engelholm LH; Adcendo ApS, Copenhagen, Denmark., Lynch C; Adcendo ApS, Copenhagen, Denmark., Mumberg D; Adcendo ApS, Copenhagen, Denmark., Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. |